Future considerations
| Issue . | Comments . |
|---|---|
| PrEP | PrEP use is increasing ↓ Will otherwise eligible gbMSM donors be deferred for PrEP use? |
| Pathogen reduction | Methods in use for source plasma, platelets, and transfusible plasma are highly effective against HIV ↓ Can eligibility criteria be modified if pathogen reduction is being performed? HIV-infected donors on PrEP or who have recently taken PrEP and have negative test results have very low viremia, so are deferrals for PrEP needed for pathogen-reduced components? |
| Trans donors | A binary donor registration system does not adequately cover the gender identity spectrum ↓ Can we modify our computer systems to be more inclusive of all potential donors? |
| Issue . | Comments . |
|---|---|
| PrEP | PrEP use is increasing ↓ Will otherwise eligible gbMSM donors be deferred for PrEP use? |
| Pathogen reduction | Methods in use for source plasma, platelets, and transfusible plasma are highly effective against HIV ↓ Can eligibility criteria be modified if pathogen reduction is being performed? HIV-infected donors on PrEP or who have recently taken PrEP and have negative test results have very low viremia, so are deferrals for PrEP needed for pathogen-reduced components? |
| Trans donors | A binary donor registration system does not adequately cover the gender identity spectrum ↓ Can we modify our computer systems to be more inclusive of all potential donors? |